Susquehanna International Group’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.4K | Buy |
+44,758
| New | +$47.4K | ﹤0.01% | 6039 |
|
|
2024
Q4 | – | Sell |
-44,160
| Closed | -$65.8K | – | 6675 |
|
|
2024
Q3 | $65.8K | Sell |
44,160
-42,457
| -49% | -$63.3K | ﹤0.01% | 5234 |
|
|
2024
Q2 | $140K | Sell |
86,617
-65,774
| -43% | -$107K | ﹤0.01% | 4955 |
|
|
2024
Q1 | $259K | Buy |
152,391
+131,537
| +631% | +$224K | ﹤0.01% | 4377 |
|
|
2023
Q4 | $64.6K | Sell |
20,854
-129,253
| -86% | -$401K | ﹤0.01% | 5488 |
|
|
2023
Q3 | $922K | Sell |
150,107
-11,374
| -7% | -$69.8K | ﹤0.01% | 2662 |
|
|
2023
Q2 | $1.01M | Sell |
161,481
-179,502
| -53% | -$1.12M | ﹤0.01% | 2704 |
|
|
2023
Q1 | $1.63M | Buy |
340,983
+279,921
| +458% | +$1.34M | ﹤0.01% | 2222 |
|
|
2022
Q4 | $531K | Sell |
61,062
-42,412
| -41% | -$369K | ﹤0.01% | 3131 |
|
|
2022
Q3 | $1.23M | Buy |
103,474
+70,621
| +215% | +$840K | ﹤0.01% | 2272 |
|
|
2022
Q2 | $468K | Sell |
32,853
-9,546
| -23% | -$136K | ﹤0.01% | 3433 |
|
|
2022
Q1 | $883K | Sell |
42,399
-6,170
| -13% | -$128K | ﹤0.01% | 2974 |
|
|
2021
Q4 | $1.12M | Buy |
48,569
+7,512
| +18% | +$174K | ﹤0.01% | 2711 |
|
|
2021
Q3 | $1.22M | Buy |
41,057
+28,948
| +239% | +$862K | ﹤0.01% | 2510 |
|
|
2021
Q2 | $414K | Buy |
+12,109
| New | +$414K | ﹤0.01% | 4114 |
|